Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 20 (1), 148-56

Selective Serotonin Reuptake Inhibitors as a Novel Class of Immunosuppressants

Affiliations
Review

Selective Serotonin Reuptake Inhibitors as a Novel Class of Immunosuppressants

Veerle Gobin et al. Int Immunopharmacol.

Abstract

In the past decades, selective serotonin reuptake inhibitors (SSRIs) have been shown to exert several immunological effects, such as reduced lymphocyte proliferation, alteration of cytokine secretion and induction of apoptosis. Based on these effects, SSRIs were proposed as drugs for the treatment of autoimmune pathologies and graft-versus-host disease. This review summarizes preclinical and clinical evidence supporting a role for SSRIs in autoimmune diseases and graft-versus-host disease, and discusses what is known about the mechanism underlying these effects.

Keywords: Autoimmune diseases; Graft-versus-host disease; Immunosuppression; Lymphocytes; Selective serotonin reuptake inhibitors.

Similar articles

See all similar articles

Cited by 14 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback